1. Home
  2. TERN

TERN

Terns Pharmaceuticals Inc.

Logo Terns Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 12:22pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

Founded: 2017 Country:
United States
United States
Employees: N/A City: FOSTER CITY
Market Cap: 332.3M IPO Year: 2021
Target Price: $14.94 AVG Volume (30 days): 901.2K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.27 EPS Growth: N/A
52 Week Low/High: $3.26 - $14.04 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 73.49%

Share on Social Networks: